≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Migraine, unspecified, drug-induced

EFO Endpoint Browser PheWeb

MIGRAINE_UNSPE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs — ANY
  • Hospital discharge: ICD-10 — G43.9#

1 out of 7 registries used, show all original rules.

260

4. Check minimum number of events

None

260

5. Include endpoints

None

260

6. Filter based on genotype QC (FinnGen only)

260

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

All Female Male
Number of individuals 260 208 52
Unadjusted period prevalence (%) 0.06 0.07 0.02
Median age at first event (years) 36.78 37.49 33.91

-FinnGen-

Age distribution of first events

010203040506070809001020304050607080AgeIndividuals

-FinnGen-

Year distribution of first events

19701975198019851990199520002023020406080100120140160180YearIndividuals

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
234
Matched controls
2338
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G43.9
ICD-10 Finland
Migraine, unspecified
+∞
270.9
234
67
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
13.3
64.6
137
224
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
23.6
56.8
84
54
N02CC03
ATC
zolmitriptan; nasal, oral
10.4
31.2
65
83
N03AX11
ATC
topiramate; oral
21.0
28.3
42
24
N02CC04
ATC
rizatriptan; oral
9.1
28.0
63
91
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
8.8
26.3
60
88
N02CC06
ATC
eletriptan; oral
15.7
25.9
43
33
N06CA01
ATC
amitriptyline and psycholeptics; systemic
6.6
23.9
68
137
N02CX04
ATC
NA
16.7
23.1
37
26
G43.8
ICD-10 Finland
Other migraine
58.1
22.6
26
5
M01AG02
ATC
tolfenamic acid; oral, rectal
4.7
21.6
88
266
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
22.1
21.5
31
16
N02CC02
ATC
naratriptan; oral
17.2
20.9
33
22
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
20.2
92
306
N02CC07
ATC
frovatriptan; oral
10.1
20.2
41
48
G43.3
ICD-10 Finland
Complicated migraine
24.3
20.0
28
13
R51.80
ICD-10 Finland
Headache
4.7
19.6
77
221
N06AA09
ATC
amitriptyline; systemic
6.4
19.5
55
107
N02CC05
ATC
almotriptan; oral
8.8
17.8
39
52
M01AE03
ATC
ketoprofen; systemic, rectal
3.2
16.0
123
598
N03AG01
ATC
valproic acid; systemic, rectal
6.6
15.8
42
75
G44.2
ICD-10 Finland
Tension-type headache
4.1
15.1
66
204
C07AA05
ATC
propranolol; systemic
3.5
14.3
82
315
3007
Kela drug reimbursment
Erenumab and fremanezumab
25.7
14.0
19
8
N05BA01
ATC
diazepam; systemic, rectal
4.4
13.9
54
148
C07AB07
ATC
bisoprolol; oral
2.8
12.2
114
596
N02AX02
ATC
tramadol; systemic, rectal
2.7
11.8
120
656
C07AB02
ATC
metoprolol; systemic
3.6
11.8
59
201
N02CD01
ATC
erenumab; parenteral
24.4
11.7
16
7
C08DA01
ATC
verapamil; systemic
7.7
11.7
27
39
G43
ICD-10 Finland
Migraine
6.1
11.7
32
59
N05AB04
ATC
prochlorperazine; systemic, rectal
14.6
11.7
19
14
N03AX12
ATC
gabapentin; oral
3.6
11.6
57
192
A02BA02
ATC
ranitidine; systemic
3.4
11.5
65
240
N89
ICPC
Migraine
8.8
11.4
24
30
M01AE02
ATC
naproxen; oral, rectal
2.6
10.4
160
1070
M03BC51
ATC
orphenadrine, combinations; systemic
2.5
9.7
96
501
M03BX02
ATC
tizanidine; oral
2.5
9.4
172
1226
C09CA06
ATC
candesartan; oral
2.8
9.2
69
304
N06AX11
ATC
mirtazapine; oral
2.5
9.1
96
513
N03AX16
ATC
pregabalin; oral
2.7
9.0
73
338
N06AX16
ATC
venlafaxine; oral
3.1
9.0
54
208
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.0
8.9
36
102
A02BC01
ATC
omeprazole; systemic
2.6
8.8
78
381
R518
ICD-10 Finland
NA
21.0
8.6
12
6
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
8.5
108
632
J01MA02
ATC
ciprofloxacin; systemic
2.3
8.2
99
563
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
8.0
74
366
G44.0
ICD-10 Finland
Cluster headache syndrome
13.7
8.0
13
10
N06AX21
ATC
duloxetine; oral
3.3
7.9
41
142
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
26.0
7.6
10
*
H02AB04
ATC
methylprednisolone; systemic
2.9
7.6
49
195
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.5
7.4
34
108
N02CD03
ATC
fremanezumab; systemic
31.0
7.2
9
*
H02AB06
ATC
prednisolone; systemic
2.1
6.9
121
791
N02CA01
ATC
dihydroergotamine; nasal, systemic
41.2
6.8
8
*
G43.2
ICD-10 Finland
Status migrainosus
23.3
6.7
9
*
M03AX01
ATC
botulinum toxin; parenteral
10.5
6.6
12
12
A02BC05
ATC
esomeprazole; systemic
2.1
6.6
109
692
N05AH04
ATC
quetiapine; oral
2.6
6.5
52
234
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
6.5
52
237
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
6.4
77
427
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.7
6.4
46
197
H02AB07
ATC
prednisone; oral
2.6
6.3
46
198
N06AB03
ATC
fluoxetine; oral
2.8
6.2
40
160
N06AB04
ATC
citalopram; systemic
2.2
6.2
69
369
R20.2
ICD-10 Finland
Paraesthesia of skin
3.5
6.1
27
83
A02BC02
ATC
pantoprazole; systemic
2.0
6.0
163
1241
R53
ICD-10 Finland
Malaise and fatigue
2.3
6.0
60
302

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
76
357
2.60
10.26
3.4
3.3
27.40
138.61
ng/l
1.51
60
248
193
1507
2.09
6.30
3.7
3.3
—
—
—
0
0
58
297
2.23
6.19
1.3
1.2
—
—
—
0
0
126
855
1.92
6.19
5.2
4.2
36.65
36.51
g/l
0.12
121
805
78
449
2.05
6.16
1.4
1.3
30.59
25.60
iu/ml
0.14
25
153
62
330
2.15
6.00
1.4
1.4
390.00
493.50
titre
0.35
12
80
72
412
2.03
5.74
2.6
2.5
7.13
7.71
e6/l
0.07
60
375
36
154
2.55
5.71
1.2
1.2
—
—
—
0
0
206
1688
2.06
5.34
4.9
3.9
9.76
10.22
mm/h
0.29
195
1557
157
1186
1.82
5.14
4.4
4.7
6.10
6.47
mmol/l
1.97
147
1089
225
1921
2.27
5.01
19.0
14.9
13.46
13.56
%
0.53
220
1893
77
479
1.86
4.70
2.4
2.0
3.32
2.93
mg/l
0.67
61
407
86
558
1.81
4.57
1.2
1.2
0.67
1.10
u/ml
1.31
20
166
91
601
1.79
4.56
3.7
3.0
27.93
36.12
e6/l
0.20
74
450
174
1382
1.78
4.54
5.2
4.2
540.80
185.30
e6/l
—
5
23
63
378
1.88
4.26
2.0
2.4
546.26
541.80
mosm/kgh2o
0.05
54
324
73
461
1.81
4.20
3.7
3.7
1.01
1.02
kg/l
—
9
55
103
719
1.72
4.18
10.3
7.1
1.06
1.11
inr
0.65
33
216
200
1681
1.82
4.03
7.3
7.1
72.07
75.78
u/l
0.90
189
1575
110
789
1.68
4.00
2.0
1.8
95.37
98.93
pmol/l
0.35
56
374
92
632
1.71
3.91
4.1
3.8
7.40
7.40
ph
0.03
18
108
143
1108
1.65
3.79
6.0
5.5
1.93
1.99
e9/l
0.21
131
989
82
550
1.72
3.79
3.3
2.8
0.23
0.42
e6/l
0.97
65
396
53
314
1.86
3.70
1.7
1.6
1125.21
1232.01
nmol/l
0.43
42
235
75
496
1.72
3.63
1.3
1.4
2.16
2.40
g/l
0.57
38
301
61
382
1.78
3.56
1.5
1.7
352.67
15528411.81
pmol/l
0.50
49
322
144
1131
1.61
3.51
5.2
5.9
10.06
10.00
umol/l
0.05
138
1071
68
442
1.73
3.48
1.3
1.3
1.33
11.02
u/ml
3.11
22
173
59
369
1.77
3.45
2.2
2.5
2.43
2.44
mmol/l
0.21
47
330
70
460
1.71
3.45
4.4
4.1
—
—
—
0
0
88
615
1.65
3.44
2.0
2.1
125.92
150.33
u/l
0.46
83
583
44
252
1.90
3.40
3.5
2.3
4.62
6.36
umol/l
1.40
39
215
74
496
1.69
3.38
2.0
1.7
1.49
0.81
mg/l
0.68
56
382
95
684
1.61
3.27
5.8
5.3
—
—
—
0
0
80
553
1.65
3.24
3.4
2.7
—
—
—
0
0
205
1778
1.72
3.20
4.5
4.2
14.08
14.56
pmol/l
2.23
192
1647
26
126
2.18
3.15
1.2
1.2
—
—
—
0
0
177
1483
1.61
3.13
4.7
3.9
—
—
—
0
0
22
100
2.31
3.09
1.0
1.0
—
—
—
0
0
48
295
1.77
2.96
2.8
2.7
2.40
3.36
e6/l
0.40
25
134
131
1034
1.54
2.95
3.0
2.7
84.57
93.92
ug/l
0.41
122
962
243
2243
2.28
2.84
16.8
11.8
18.33
20.77
mg/l
0.65
205
1695
116
899
1.52
2.80
5.6
5.9
1.22
1.22
mmol/l
0.33
107
826
124
975
1.52
2.79
8.7
8.5
0.00
0.00
e9/l
0.95
101
793
135
1081
1.52
2.79
6.1
5.5
0.04
0.04
e9/l
0.15
118
947
96
716
1.54
2.75
3.4
3.2
17.93
22.58
ng/l
0.37
52
427
124
980
1.51
2.70
6.4
6.6
1.22
1.22
mmol/l
0.31
100
835
134
1077
1.50
2.69
6.2
5.5
0.53
0.54
e9/l
0.38
117
944
97
730
1.52
2.65
4.4
3.5
92.37
57.47
e6/l
0.31
76
487
94
704
1.53
2.62
2.1
3.3
2.36
2.36
mmol/l
0.02
82
625
230
2094
1.85
2.62
5.4
4.9
1.92
2.38
mu/l
0.38
214
1954
128
1024
1.49
2.60
6.4
5.4
57.56
56.67
%
0.37
119
967
8
20
4.09
2.59
2.4
1.8
—
—
—
0
0
8
20
4.09
2.59
2.4
1.8
—
—
—
0
0
8
20
4.09
2.59
2.4
1.8
—
—
—
0
0
8
20
4.09
2.59
2.4
1.8
—
—
—
0
0
82
598
1.54
2.58
3.4
2.6
—
—
—
0
0
138
1125
1.48
2.53
6.2
5.8
0.18
0.18
e9/l
0.15
129
1001
38
230
1.76
2.47
1.9
1.5
—
—
—
0
0
131
1063
1.47
2.42
3.9
3.3
0.00
0.00
estimate
0.00
20
209
152
1273
1.47
2.37
7.2
9.4
4.15
3.93
e9/l
0.55
132
1122
81
601
1.51
2.32
2.0
1.6
1.39
1.39
mmol/l
0.00
67
519
13
53
2.53
2.31
3.7
2.7
—
—
—
0
0
131
1070
1.45
2.30
4.9
4.5
0.00
0.00
estimate
0.00
23
211
132
1083
1.44
2.25
3.9
3.4
0.00
0.00
estimate
0.00
22
200
127
1036
1.44
2.23
6.6
5.6
29.23
28.88
%
0.14
119
976
7
19
3.76
2.16
1.7
1.2
—
—
—
0
0
32
193
1.75
2.12
1.1
1.2
—
—
—
0
0
66
483
1.49
2.00
3.7
3.4
—
—
—
0
0
5
11
4.61
1.95
2.2
1.3
—
—
—
0
0
118
968
1.40
1.93
6.6
5.6
0.65
0.72
%
0.59
110
903
103
831
1.40
1.83
3.5
3.1
—
—
—
0
0
21
117
1.86
1.80
2.3
2.8
—
—
—
0
0
230
2143
1.63
1.77
4.2
4.1
5.65
5.79
mmol/l
1.06
213
1994
69
523
1.43
1.73
1.7
2.6
302.73
6321.81
umol/l
2.51
52
464
31
197
1.65
1.72
1.2
1.2
176.13
172.89
iu/ml
0.01
11
85
5
13
3.90
1.72
1.4
1.4
1.82
1.89
mmol/l
—
5
13
40
272
1.56
1.70
2.2
2.2
2.33
2.45
g/l
0.73
33
254
7
25
2.85
1.66
1.7
2.3
—
—
—
0
0
120
1007
1.36
1.63
7.1
5.8
8.11
8.37
%
0.54
112
951
8
32
2.55
1.61
1.3
1.1
—
—
—
0
0
119
1001
1.35
1.58
6.8
5.5
2.83
2.78
%
0.10
111
937
12
57
2.16
1.57
1.6
2.1
—
—
—
0
0
43
310
1.46
1.40
2.1
2.1
151.94
106.55
ug/g
0.44
33
243
9
42
2.18
1.35
1.4
1.8
—
—
—
0
0
16
91
1.81
1.32
1.6
1.5
—
—
—
0
0
16
91
1.81
1.32
12.0
14.5
—
—
—
0
0
59
457
1.38
1.30
1.5
1.5
21.97
22.42
nmol/l
0.08
50
385
217
2029
1.42
1.29
5.0
5.1
37.97
38.91
mmol/mol
0.81
204
1910
11
55
2.04
1.29
1.3
1.2
3.92
3.73
mmol/l
0.35
11
49
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
10
49
2.08
1.23
3.6
2.0
104.15
153.73
ug/l
—
10
43
10
49
2.08
1.23
1.5
1.4
—
—
—
0
0
5
19
2.66
1.22
1.0
3.7
—
—
—
0
0
15
86
1.79
1.22
1.7
1.5
—
—
—
0
0
35
250
1.46
1.21
1.3
1.3
—
—
—
0
0
6
26
2.34
1.19
1.0
1.3
—
—
—
0
0
13
73
1.82
1.13
1.2
1.2
—
—
—
0
0
67
543
1.32
1.10
2.9
4.8
—
—
—
0
0
7
32
2.22
1.09
1.7
3.5
—
—
—
0
0
38
282
1.41
1.08
3.0
2.2
—
—
—
0
0
23
156
1.52
1.02
1.3
1.4
—
—
—
0
0
244
2353
1.60
1.02
15.3
11.0
—
—
—
0
0
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
9
51
1.79
0.95
1.1
1.2
—
—
—
0
0
68
565
1.28
0.93
5.6
7.0
—
—
—
0
0
6
28
2.17
0.92
1.3
1.4
—
—
—
0
0
11
63
1.78
0.91
1.0
1.8
—
—
—
0
0
6
29
2.09
0.90
1.3
1.3
—
—
—
0
0
13
79
1.68
0.90
1.6
2.1
17.86
4348.00
u/l
—
5
27
6
31
1.96
0.85
1.5
1.3
—
—
—
0
0
10
57
1.78
0.85
1.1
1.1
—
—
—
0
0
22
155
1.46
0.84
2.7
3.2
—
—
—
0
0
12
188
0.62
0.83
1.3
1.4
—
—
—
0
0
25
182
1.41
0.81
4.2
3.5
—
—
—
0
0
8
47
1.72
0.81
1.9
1.6
—
—
—
0
0
0
25
0.00
0.79
0.0
1.0
—
1.74
—
0
8
12
75
1.63
0.76
1.7
1.5
—
—
—
0
0
24
176
1.40
0.76
8.1
10.4
96.40
96.04
%
0.18
24
171
7
38
1.86
0.74
2.7
1.7
—
—
—
0
0
67
574
1.23
0.70
4.8
3.8
0.00
0.00
estimate
0.50
22
208
21
153
1.41
0.69
1.3
1.4
—
—
—
0
0
26
197
1.36
0.69
8.0
10.1
1.27
1.45
mmol/l
0.09
21
162
15
104
1.47
0.64
2.1
2.3
—
—
—
0
0
32
254
1.30
0.63
1.5
1.5
—
—
—
0
0
70
610
1.20
0.62
3.5
2.9
—
—
—
0
0
104
940
1.18
0.61
2.2
2.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
3.0
—
—
—
0
0
12
172
0.68
0.58
2.9
3.9
—
—
—
0
0
6
36
1.68
0.57
1.2
1.1
—
—
—
0
0
17
125
1.39
0.55
1.1
1.1
—
—
—
0
0
82
912
0.85
0.55
2.7
2.7
—
—
—
0
0
6
38
1.59
0.54
2.3
3.1
26.47
24.32
mmol/l
—
6
31
6
39
1.55
0.53
1.2
1.1
—
—
—
0
0
18
135
1.36
0.52
3.2
2.0
8.02
4.23
ug/l
0.51
18
119
217
2096
1.21
0.52
19.1
12.7
39.39
40.39
%
1.01
174
1645
16
118
1.38
0.51
1.1
1.1
—
—
—
0
0
10
68
1.49
0.47
2.1
3.2
—
—
—
0
0
67
596
1.17
0.47
2.6
2.9
7.93
7.32
mmol/l
0.48
55
499
32
266
1.23
0.46
1.5
1.4
—
—
—
0
0
6
91
0.65
0.43
4.2
2.5
—
—
—
0
0
254
2507
1.57
0.43
23.4
17.8
135.43
135.24
g/l
0.08
254
2474
254
2505
1.61
0.43
23.2
17.6
30.10
30.23
pg
0.68
254
2473
254
2505
1.61
0.43
23.2
17.7
90.32
90.84
fl
1.15
254
2473
13
96
1.37
0.42
2.0
3.1
5.39
5.09
kpa
0.59
13
88
10
70
1.45
0.42
1.1
1.1
—
—
—
0
0
5
33
1.52
0.41
1.4
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
0
19
0.00
0.39
0.0
2.6
—
105.53
—
0
19
0
19
0.00
0.39
0.0
2.6
—
3.99
—
0
19
11
80
1.39
0.39
7.9
6.1
—
—
—
0
0
32
273
1.20
0.37
2.0
1.4
—
—
—
0
0
5
37
1.36
0.37
1.8
1.7
—
—
—
0
0
25
298
0.82
0.37
1.2
1.3
—
—
—
0
0
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
6
43
1.40
0.35
1.3
1.1
—
—
—
0
0
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
6
44
1.37
0.34
1.8
1.6
33.50
36.20
nmol/l
—
6
44
57
628
0.88
0.33
1.6
1.5
—
—
—
0
0
19
156
1.24
0.32
5.9
6.5
1.26
1.20
mmol/l
0.12
19
150
49
440
1.14
0.31
1.8
1.8
—
—
—
0
0
109
1030
1.10
0.29
4.2
3.9
—
—
—
0
0
231
2269
1.16
0.28
4.9
4.6
2.94
2.89
mmol/l
0.34
214
2118
228
2238
1.15
0.27
4.3
4.2
4.86
4.86
mmol/l
0.01
217
2101
25
285
0.86
0.24
1.4
1.2
—
—
—
0
0
5
39
1.29
0.23
1.4
2.0
—
—
—
0
0
5
40
1.25
0.22
2.8
3.1
3.57
4.80
e9/l
—
5
40
19
163
1.18
0.22
2.2
2.5
0.65
0.73
ug/l
—
10
91
5
41
1.22
0.22
2.8
3.6
60.00
58.51
%
—
5
41
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
2.1
—
725.60
—
0
5
0
10
0.00
0.21
0.0
2.1
—
536.00
—
0
5
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
226
2225
1.12
0.21
4.3
4.1
1.49
1.54
mmol/l
1.01
213
2080
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
57
531
1.09
0.20
2.7
3.1
1164.66
313.04
mg/l
0.34
38
315
16
136
1.19
0.20
11.4
8.0
—
—
—
0
0
18
155
1.17
0.20
6.9
3.4
—
—
—
0
0
58
542
1.09
0.20
3.2
3.2
—
—
—
0
0
7
58
1.21
0.18
2.1
3.4
23.99
24.79
mmol/l
—
7
58
28
254
1.11
0.16
1.9
1.8
—
—
—
0
0
39
361
1.09
0.16
1.5
1.6
—
—
—
0
0
11
92
1.20
0.16
1.1
1.2
—
—
—
0
0
9
80
1.13
0.15
1.8
1.6
—
—
—
0
0
59
559
1.07
0.15
3.6
3.9
7.58
8.18
mg/mmol
0.04
34
320
10
84
1.20
0.14
8.3
2.3
1.17
1.28
%
—
10
84
13
113
1.16
0.13
8.5
8.8
—
—
—
0
0
16
142
1.14
0.13
2.6
2.8
72.02
75.13
e9/l
—
10
105
19
209
0.90
0.11
2.4
3.8
2.26
8.68
ug/l
1.88
11
170
18
198
0.90
0.11
1.2
1.3
—
—
—
0
0
11
123
0.89
0.08
16.0
7.7
9.17
8.27
mmol/l
0.22
11
116
6
70
0.85
0.07
6.5
4.3
—
—
—
0
0
9
101
0.89
0.06
3.1
1.8
—
—
—
0
0
25
238
1.06
0.05
1.4
1.7
—
—
—
0
0
68
665
1.03
0.05
2.7
2.1
—
—
—
0
0
15
140
1.08
0.04
3.8
2.5
—
—
—
0
0
213
2143
0.97
0.04
3.8
3.8
1.30
1.28
mmol/l
0.18
195
1993
11
102
1.08
0.03
6.4
5.5
24.30
25.15
mmol/l
0.44
11
102
17
163
1.05
0.01
1.4
1.9
—
—
—
0
0
22
221
1.00
0.00
1.6
1.4
—
—
—
0
0
18
183
0.98
0.00
4.1
2.4
0.20
0.23
g/l
0.77
18
173
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
5
51
0.98
0.00
1.4
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
8.6
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
10.71
—
0
6
0
6
0.00
0.00
0.0
1.2
—
1.20
—
0
6
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.5
—
1.61
—
0
6

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: MIGRAINE_UNSPE – Migraine, unspecified, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).